臨床試験アウトソーシングサービスの世界市場2015-2025...市場調査レポートについてご紹介

【英文タイトル】Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of the World Market for Pharma Clinical Trial Services
1.2 Why Should You Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain

2. An Introduction to Clinical Trial Outsourcing
2.1 A Brief History of Clinical Trials
2.2 Clinical Trial Design and Execution
2.2.1 Phases of Clinical Trials
2.2.1.1 Phase I Trials: First-In-Human Studies
2.2.1.2 Phase II Trials: Proof-Of-Concept
2.2.1.3 Phase III Trials: Preparing for Approval Applications
2.2.1.4 Post-Marketing Studies
2.2.2 Key Elements of Clinical Trials
2.2.3 Common Trial Designs
2.2.3.1 Improving Clinical Trial Models through Adaptive Trial Designs
2.3 Clinical Trial Outsourcing
2.3.1 Challenges Exist in Conducting Clinical Trials
2.3.2 Benefits of Outsourcing

3. Pharma Clinical Trial Services: World Market 2015-2025
3.1 The World Pharma Clinical Trial Services Market in 2013 and 2014
3.1.1 The Impact of the Economy on the Clinical Trial Services Market, 2008-2014
3.1.2 CRO Revenue by Trial Phase 2014
3.1.3 Big Pharma Companies Are the Leading Clients for CROs
3.2 The Pharma Clinical Trial Services Market 2015-2025
3.2.1 What Will Drive Growth in Clinical Trial Outsourcing 2015-2025?
3.2.2 The Pharma Clinical Trial Services Market: Overall Revenue Forecast 2015-2025
3.2.3 Which Market Sector Will Account for the Most Revenue from 2015-2025?
3.3 Early Phase Clinical Trial Services 2015-2025
3.3.1 Rising Demand for Early Phase Services throughout the Decade
3.3.2 Biotech Outsourcing to Drive Early Phase Growth
3.4 Late Phase Clinical Trial Services 2015-2025
3.4.1 Late Phase Clinical Trial Services: The Largest Market Sector 2015-2025
3.4.2 Focus on Late-Stage Pipeline Candidates Early in the Decade

4. Pharma Clinical Trial Services: Leading Developed National Markets 2015-2025
4.1 Leading National Markets for Pharma Clinical Trial Services 2014
4.2 Pharma Clinical Trial Services: Leading National Market Forecasts 2015-2025
4.3 North America as a Destination for Clinical Trials
4.3.1 The US: The Largest National Market for Clinical Trial Services 2015-2025
4.3.1.1 Regulatory Developments to Improve Clinical Trials in the US
4.3.2 The US: Clinical Trial Service Revenue Forecast 2015-2025
4.4 The Outlook for Clinical Trial Services in the EU5 2015-2025
4.4.1 Rewriting the Rules for Clinical Trials in the EU: Clinical Trials Regulation
4.4.2 EU5: Overall Market and Leading National Market Forecasts 2015-2025
4.4.3 Germany Is the Largest Market for Clinical Trial Services in Western Europe
4.4.4 The UK
4.4.4.1 Overcoming Challenges in UK Clinical Trials
4.4.4.2 UK Clinical Trial Services Market Forecast 2015-2025
4.4.5 France: Market Forecast 2015-2025
4.4.6 Italy: Market Forecast 2015-2025
4.4.7 Spain: Market Forecast 2015-2025
4.5 Japan Is Being Challenged by Neighbouring Emerging Markets
4.5.1 Regulatory Policies Driving and Restraining Growth in Japan
4.5.2 Growth for Clinical Trial Services in Japan 2015-2025

5. Pharma Clinical Trial Services: Leading Emerging National Markets 2015-2025
5.1 Leading Emerging Markets for Clinical Trial Services 2014
5.1.1 Benefits of Conducting Clinical Trials in Emerging Markets
5.1.2 Challenges of Conducting Clinical Trials in Emerging Markets
5.2 Strong Growth Forecast for Emerging Clinical Trial Service Markets 2015-2025
5.3 Clinical Trials in Asia Pacific: An Emerging Market Perspective
5.3.1 China Will be the Largest Emerging Market for Clinical Trials Services in 2025
5.3.1.1 CRO Investments and Partnerships in China
5.3.1.2 Chinese Clinical Trial Services Market Forecast 2015-2025
5.3.1.3 China Offers Many Advantages in Clinical Trials
5.3.1.4 New Guidelines by the China Food and Drug Administration (CFDA)
5.3.2 India as a Hub for Clinical Trials
5.3.2.1 Increasingly Strict Regulatory Procedures in India
5.3.2.2 Indian Clinical Trial Services Market Forecast 2015-2025
5.3.3 South Korea
5.3.3.1 Improving the Appeal of South Korea
5.3.3.2 Promoting Local Drug Development in South Korea
5.3.3.3 Growth in the South Korean Clinical Trials Services Market 2015-2025
5.4 Clinical Trial Outsourcing in Central and Eastern Europe (CEE)
5.4.1 Russia
5.4.1.1 Changing Clinical Trial Demands 2010-2015
5.4.1.2 Russian Clinical Trial Services Market Forecast 2015-2025
5.4.2 CEE: Clinical Trial Services Market Forecast 2015-2025
5.5 Latin America: Proximity to the US as a Growth Driver
5.5.1 Brazil: The Largest Market for Clinical Trials in Latin America 2015-2025
5.5.1.1 Brazilian Clinical Trial Services Market Forecast 2015-2025

6. Leading Disease Market Sectors for Clinical Trial Services 2015-2025
6.1 Rise in Clinical Trials, 2000-2015
6.2 The Pharma Clinical Trial Services Market by Therapeutic Area 2014-2015
6.3 The Pharma Clinical Trial Services Market: Revenue Forecasts by Therapeutic Area 2015-2025
6.3.1 Imaging for CNS and Cardiovascular Clinical Trials
6.4 Cancer Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.4.1 Biomarkers and Companion Diagnostic Development
6.4.2 Optimising Patient Recruitment and Retention
6.4.3 Many Factors Complicate Cancer Clinical Trials
6.4.4 Will Cancer Be the Largest Submarket for Clinical Trial Services 2015-2025?
6.5 Cardiovascular Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.5.1 Strong Growth in the Cardiovascular Disease Clinical Trial Services Submarket 2015-2025
6.6 CNS Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.6.1 Late-Stage Failures in Alzheimer’s Pipeline, 2009-2014
6.6.2 Concerns with Placebo Response Rates in CNS Clinical Trials
6.6.2.1 Cogtest Clinical: Data Capture and Cognitive Assessment
6.6.3 Effective Use of Adaptive Trial Designs
6.6.4 CNS Clinical Trials: Submarket Forecast 2015-2025
6.7 Infectious Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.7.1 Challenges in the Use of Non-Inferiority Trials
6.7.2 Considerations for Antibacterial Drug Clinical Trials
6.7.3 Vaccine Clinical Trials and Emerging Markets
6.7.4 Infectious Disease Clinical Trial Services Submarket Forecast 2015-2025
6.8 Metabolic Disease Clinical Trials: Key Trends and Submarket Forecast 2015-2025
6.8.1 Assessing Cardiovascular Risks in Diabetes
6.8.2 Metabolic Disease Clinical Trial Services Submarket Forecast 2015-2025
6.9 Therapeutic Expertise Provides an Opportunity for Specialisation
6.9.1 CROs Offering Imaging Services

7. Pharma Clinical Trial Services Market: Industry Trends 2015-2025
7.1 Pharma Clinical Trial Services Market: Strengths and Weaknesses 2014
7.2 Pharma Clinical Trial Services Market: Opportunities and Threats 2015-2025
7.2.1 Opportunities for CROs in Biosimilar Development
7.3 Pharma Clinical Trial Services Market: STEP Analysis 2015-2025
7.4 Social Factors Affecting Clinical Trials 2015-2025
7.4.1 Drug Developers Must Deal with Ethical Considerations to Clinical Trials
7.4.2 Patient Recruitment: The Leading Cause of Trial Delays
7.4.3 Investing to Maintain Patient Enrolment
7.4.3.1 Social Media as a Tool for Engaging Patients in Trials
7.5 Improving Technology for More-Efficient Trials
7.5.1 eClinical Trial Tools
7.5.1.1 Electronic Health Records for Faster Patient Recruitment
7.5.2 Cloud Computing as a Tool for Multicentre Trials
7.5.3 Electronic Data Capture
7.6 Economic Considerations for Clinical Trial Outsourcing
7.6.1 Pharma is Adjusting its R&D Strategies
7.6.2 CROs are Attractive for Private Investors
7.7 Political and Regulatory Developments Affecting Clinical Trials
7.7.1 Drug Safety and Clinical Trials Post-Approval
7.7.2 Cutting Red Tape and Other Regulatory Developments
7.8 Future Growth Strategies for CROs
7.8.1 Strategic Partnering for Long Term Revenue Growth
7.8.1.1 Sharing Risk Between Pharma and CROs
7.8.2 What Strategies Are Used for Selecting a CRO?
7.8.2.1 Small Pharmaceutical Companies and CROs
7.8.3 CRO Consolidation is Decreasing the Number of Mid-Sized Market Players
7.8.4 CROs Can Specialise to Grow
7.8.4.1 Orphan Diseases Are an Opportunity for Specialisation
7.9 The Future of Clinical Trials and CROs
7.9.1 New Trial Designs
7.9.1.1 Optimising Clinical Trials for Efficient Drug Development
7.9.2 Clinical Trial Globalisation
7.9.2.1 Consequences of Increased Outsourcing to Emerging Markets
7.9.3 Clinical Trials Have Become Increasingly Complex
7.10 Biomarkers Are Useful Tools for Accelerating Drug Development

8. Leading CROs in the Clinical Trials Services Industry in 2015
8.1 The Pharma Clinical Trial Services Market by Company 2014
8.2 Quintiles: The Largest Player in the Pharma Clinical Trial Services Market
8.2.1 Embracing Technology for New Service Offerings
8.2.2 How Quintiles Remains a Leader in the Clinical Trials Market
8.2.2.1 An Increase in Emerging Biotech Customers in 2014
8.2.2.2 Expanding in Developed and Emerging Markets
8.2.3 Will Quintiles Remain the Market Leader to 2025?
8.3 Covance Acquired by Laboratory Corporation of America (LabCorp)
8.3.1 Covance Drug Development
8.3.2 Covance Reorganises its Early Phase Sites
8.3.3 Strong Late Phase Revenue Growth 2010-2014
8.3.4 How Will Covance Drug Development Extend its Services Beyond 2014?
8.4 Pharmaceutical Product Development (PPD)
8.4.1 PPD: Another Global CRO to be Taken Private
8.4.2 Investing in Technology for Growth
8.4.3 PPD: Outlook 2015-2025
8.5 Parexel International
8.5.1 Parexel is Targeting Growth in Asia
8.5.2 Strong Growth for Clinical Trial Services 2010-2014
8.5.3 New Areas of Specialisation for Parexel
8.6 ICON
8.6.1 Multiple Acquisitions Have Increased ICON’s Service Range
8.6.1.1 Expanding Operations in China
8.6.2 ICON: Recent Financial Performance and Outlook 2015-2025
8.7 INC Research
8.7.1 From Mid-Sized to Large CRO: INC Acquires Kendle
8.7.2 INC Adds New Technological Capabilities
8.8 inVentiv Health
8.8.1 Four Acquisitions Move inVentiv Closer to the Big Players
8.8.2 Clinical Trial Service Revenue Growth 2011 and Beyond
8.9 PRA Health Sciences
8.9.1 New Site Openings in Emerging Markets 2011-2014
8.9.2 Future Directions for PRA Health Sciences
8.10 CMIC Holdings: Japan’s Largest CRO
8.10.1 Increasing Asian Regional Reach
8.10.2 CMIC Recent and Future Performance Analysis: An Asian Specialist
8.11 Chiltern International
8.11.1 Expanding into New Emerging Markets with Expansion in Israel, Taiwan and Singapore
8.11.2 Chiltern International: Opportunities for Growth 2015-2025
8.12 There Are Many Other CROs in the Market in 2015
8.12.1 Charles River Laboratories Is an Expert in Pre-Clinical Services
8.12.2 Clinipace Worldwide Is a Digital CRO
8.12.2.1 Rapidly Expanding Through Acquisitions
8.12.2.2 Clinipace Offers Many Technology Solutions
8.12.3 Theorem Clinical Research
8.12.3.1 An Established Presence in China
8.12.4 WuXi PharmaTech
8.12.4.1 WuXi is New to the Clinical Trial Services Market
8.13 Leading Company Analysis
8.13.1 Emerging Market Entry and Expansion
8.13.2 How Are Global CROs Expanding Their Service Offerings and Utilising Technology?
8.13.3 How Are Leading Players Seeking to Differentiate Themselves?
8.13.4 Medium-Sized Players Growing Larger Through Multiple Acquisitions
8.13.5 Large CROs and Strategic Partnerships with Big Pharma

9. Research Interviews from Our Survey
9.1 Interview with Mark Egerton, CEO of Quotient Clinical
9.1.1 Quotient Clinical’s Translational Pharmaceutics Platform
9.1.2 Quotient Clinical in the Global Market
9.1.3 Challenges for the Pharma Clinical Trial Services Market
9.1.4 Pharma Clinical Trial Services Market Size, 2015-2025
9.2 Interview with Dean Knuth, Executive Director Clinical Sciences of MPI Research
9.2.1 On Changes in the Outsourcing Market
9.2.2 MPI Research Acquires Jasper Clinical
9.2.3 Future Outlook for MPI Research
9.2.4 Drivers and Restraints in Early Phase Clinical Trial Services
9.2.5 Technological Advances in Clinical Trials Services
9.2.6 On the Early Phase Development Market Size
9.3 Interview with Ewan Campbell, Director of The Clinical Trial Company
9.3.1 Clinical Trial Services Offered at TCTC
9.3.2 Drivers and Restraints for Outsourcing Late-Phase Development
9.3.3 Potential Impact of the EU Clinical Trial Regulation on the Clinical Trial Services
9.3.4 Trends Affecting the Clinical Trial Services Market, 2015-2025

10. Conclusions from Our Research and Analysis
10.1 The State of the Clinical Trial Services Market in 2014
10.1.1 A Market Dominated by the Developed Countries
10.2 Strong Growth for the Overall Market 2015-2025
10.3 Which CROs Can Take Best Advantage of Market Growth in the Next 10 Years?
10.3.1 The Role of Technology in the Future of Clinical Trial Services
10.3.2 How Can CROs Specialise to Remain Competitive?


【レポート販売概要】

■ タイトル:臨床試験アウトソーシングサービスの世界市場2015-2025
■ 英文:Pharma Clinical Trial Services: World Industry and Market Prospects 2015-2025
■ 発行日:2015年6月
■ 調査会社:visiongain
■ 商品コード:VGAIN50614
■ 調査対象地域:グローバル
  • 世界のニンニク市場:種類別、地域別
    Global Garlic Market: About this market Technavio’s garlic market analysis considers sales from both hardneck garlic and softneck garlic types. Our study also finds the sales of garlic in APAC, Europe, MEA, North America, and South America. In 2019, the hardneck garlic segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as variety o …
  • 交通システム及び分析市場(世界市場予測と分析)
    In transportation systems and analytics market research repot, transportation system is defined as a term which is composed of the solutions, products, and applications that helps in improving the efficiency of the system. Hyper-urbanization, globalization, and constantly changing travel demand have been the growth driver behind the increasing use of advanced system. The solutions such as transpor …
  • 内部神経刺激の世界市場:脊髄刺激、脳深部刺激、仙椎神経刺激、迷走神経刺激、胃電気刺激
    Internal neurostimulation involves a surgical implantation of electrodes at specific areas, either in the dura mater or deep inside the brain. Medical practitioners measure the invasiveness of any surgical procedure or therapeutic device, based on incision size, collateral tissue damage, and recovery period. Thus, minimally invasive technologies are surgical techniques that reduce the physical imp …
  • 世界の農業用フィルム市場2015
    The Global Agricultural Films Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Agricultural Films industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Agricultural Films market analysis is provided for the international markets including development t …
  • 発熱性好中球減少症(Febrile Neutropenia):世界の治験レビュー2014年下半期版
    Febrile Neutropenia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Febrile Neutropenia Global Clinical Trials Review, H2, 2014" provides data on the Febrile Neutropenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Febrile Neutropenia. It includes an overview of the trial numbers and their recru …
  • ソリッドステートドライブ(SSD)の世界市場:SLC、MLC、TLC
    About solid state drives A solid state drive is a solid state disk or an electronic disk that is used for data storage. It is made of semiconductors and uses the same input/output interface design as HDDs and stores data in solid state memory. These devices use DRAM or NAND-based flash memory to store data. The lack of moving parts reduce the risk of mechanical failures of SSDs allowing data trans …
  • ウエハ製造装置の世界市場2016-2020
    About Wafer Fab Equipment The wafer fab equipment used in the manufacturing of 32 nanometer (nm) node integrated circuits (ICs) contributed 32.18% of the total market in 2015. The foundry segment is the largest revenue contributor, and accounted for a revenue share of 62.98% in 2015 APAC has been the major revenue generator to the market, and contributed a total amount of $23.52 billion in 2015 Te …
  • Perenco:石油・ガスバリューチェーン分析レポート2013
    Perenco Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Perenco" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Perenco”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business structure, …
  • IED(インテリジェント電子装置)の世界市場2015-2019
    About intelligent electronic device The intelligent electronic devices (IED) plays a significant role in automating substations and efficient monitoring of power delivery systems. IED is used in the power system to define devices that have electrical protection and monitoring functionalities with an advanced intelligent control system and can perform two-way communication with SCADA system. Moreov …
  • 大判プリンター(LFP)の世界市場動向・予測(~2022)
    The global large format printer market is expected to exhibit a moderate growth potential by 2022. The global market is expected to reach USD 8.42 Billion which includes both hardware and after-sales services, and the market is expected to witness a shipment of 398.3 thousand units by 2022, at a CAGR of 3.0% and 4.4%, respectively between 2016 and 2022. The increasing demand for large format print …
  • オマーンの通信、モバイル、ブロードバンド市場
    Executive summary Many positive aspects to Oman’s telecoms market Oman’s mobile market has a healthy level of competition, made up of two mobile operators, Oman Mobile and Nawras (rebranded as Ooredoo in 2014) and a number of MVNOs; which have captured over 10% of the mobile subscriber market share. Oman possesses a highly developed mobile market, with penetration levels indicating multiple SIM ca …
  • 世界の軍事シミュレーション、モデリング、仮想訓練市場:没入型/対話型/構築型コンピューターベース訓練システム
    A successful military force requires effective and high quality training to overcome any and all challenges. Military simulation and virtual training systems are viewed as highly important for the training of a modern and advanced military force. These simulation systems are employed to provide realistic mission training in a safe environment, where data analytics and operational review can be und …
  • 新TVプラットフォーム市場
    Over the last few years, video offerings have become richer, more fragmented and more interactive. Control of the service consumption platform has become a major issue of managing the link with consumers and monetising services. Three major industries are now teaming up or competing in the connected TV platforms market: Internet giants, Broadcasters and distributors of television services, Consume …
  • ウォールオーブン(壁埋め込み式オーブン)の世界市場
    About Wall Oven The global home appliances market has begun to register healthy growth on account of the growing middle-class economy coupled with improved disposable income levels in many regions. However, demand for generic home appliances has reached a stable stage in mature markets like the US and parts of Europe. Also, the market for smart white goods and built-in appliances is increasing owi …
  • 作物油濃縮物(COC)の世界市場予測(~2025年)
    “The crop oil concentrates market is projected to grow at a CAGR of 4.1%, in terms of value. The key drivers include the emergence of high surfactant oil concentrate and the need to reduce the pesticide application rate per hectare.” The crop oil concentrates market is estimated to be valued at USD 199 million in 2019 and is projected to grow at a CAGR of 4.1%, recording a value of USD 254 million …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。